▶ 調査レポート

再発多形性膠芽腫（GBM）治療の世界市場：市場規模・現状・予測
• 英文タイトル：Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。再発多形性膠芽腫（GBM）治療の世界市場：市場規模・現状・予測 / Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size, Status and Forecast 2019-2025 / QYR9ST05019資料のイメージです。• レポートコード：QYR9ST05019
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療・製薬
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
※当調査レポートでは、再発多形性膠芽腫（GBM）治療の世界市場について調査・分析し、再発多形性膠芽腫（GBM）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口薬、テモゾロミド、放射線増感剤、ニトロソ尿素薬、放射線療法、化学療法）、用途別（病院、診療所、外来手術センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の再発多形性膠芽腫（GBM）治療市場動向
・主要企業別マーケットシェア
・再発多形性膠芽腫（GBM）治療の種類別市場規模2014-2019
（経口薬、テモゾロミド、放射線増感剤、ニトロソ尿素薬、放射線療法、化学療法）
・再発多形性膠芽腫（GBM）治療の用途別市場規模2014-2019
（病院、診療所、外来手術センター）
・再発多形性膠芽腫（GBM）治療の北米市場：主要企業・種類別/用途別市場規模
・再発多形性膠芽腫（GBM）治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・再発多形性膠芽腫（GBM）治療の中国市場：主要企業・種類別/用途別市場規模
・再発多形性膠芽腫（GBM）治療の日本国内市場：主要企業・種類別/用途別市場規模
・再発多形性膠芽腫（GBM）治療の東南アジア市場：主要企業・種類別/用途別市場規模
・再発多形性膠芽腫（GBM）治療のインド市場：主要企業・種類別/用途別市場規模
・再発多形性膠芽腫（GBM）治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Astrazeneca、Roche、GlaxoSmithKline、Merck、Pfizer、AngioChem、Vascular Biogeneics）
・再発多形性膠芽腫（GBM）治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain.The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market.
In 2018, the global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Recurrent Glioblastoma Multiforme (GBM) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Recurrent Glioblastoma Multiforme (GBM) Treatment development in United States, Europe and China.

The key players covered in this study
Astrazeneca
Roche
GlaxoSmithKline
Merck
Pfizer
AngioChem
Vascular Biogeneics
…

Market segment by Type, the product can be split into
Oral Medications
Temozolomide
Radiosensitizers
Nitrosoureas Drugs
Radiation Therapy
Chemotherapy

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Recurrent Glioblastoma Multiforme (GBM) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Recurrent Glioblastoma Multiforme (GBM) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Recurrent Glioblastoma Multiforme (GBM) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral Medications
1.4.3 Temozolomide
1.4.4 Radiosensitizers
1.4.5 Nitrosoureas Drugs
1.4.6 Radiation Therapy
1.4.7 Chemotherapy
1.5 Market by Application
1.5.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size
2.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Growth Trends by Regions
2.2.1 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Regions (2014-2025)
2.2.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Manufacturers
3.1.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players Head office and Area Served
3.3 Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Product/Solution/Service
3.4 Date of Enter into Recurrent Glioblastoma Multiforme (GBM) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2014-2019)
4.2 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2014-2019)
5.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in United States
5.3 United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
5.4 United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application

6 Europe
6.1 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2014-2019)
6.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in Europe
6.3 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
6.4 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application

7 China
7.1 China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2014-2019)
7.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in China
7.3 China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
7.4 China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application

8 Japan
8.1 Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2014-2019)
8.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in Japan
8.3 Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
8.4 Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2014-2019)
9.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
9.4 Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application

10 India
10.1 India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2014-2019)
10.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in India
10.3 India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
10.4 India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2014-2019)
11.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in Central & South America
11.3 Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
11.4 Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application

12 International Players Profiles
12.1 Astrazeneca
12.1.1 Astrazeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
12.1.4 Astrazeneca Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
12.1.5 Astrazeneca Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
12.2.4 Roche Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
12.2.5 Roche Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
12.3.4 GlaxoSmithKline Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
12.4.4 Merck Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
12.5.4 Pfizer Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 AngioChem
12.6.1 AngioChem Company Details
12.6.2 Company Description and Business Overview
12.6.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
12.6.4 AngioChem Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
12.6.5 AngioChem Recent Development
12.7 Vascular Biogeneics
12.7.1 Vascular Biogeneics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
12.7.4 Vascular Biogeneics Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
12.7.5 Vascular Biogeneics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Recurrent Glioblastoma Multiforme (GBM) Treatment Key Market Segments
Table Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Covered
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type 2014-2025
Figure Oral Medications Figures
Table Key Players of Oral Medications
Figure Temozolomide Figures
Table Key Players of Temozolomide
Figure Radiosensitizers Figures
Table Key Players of Radiosensitizers
Figure Nitrosoureas Drugs Figures
Table Key Players of Nitrosoureas Drugs
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Recurrent Glioblastoma Multiforme (GBM) Treatment Report Years Considered
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2014-2025 (Million US$)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Regions 2014-2019
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Regions 2014-2019
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Manufacturers in 2018
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Product/Solution/Service
Table Date of Enter into Recurrent Glioblastoma Multiforme (GBM) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Share by Type (2014-2019)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type (2014-2019)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Share by Application (2014-2019)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Application in 2018
Figure United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2018-2019)
Table United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2014-2019)
Table United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2014-2019)
Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2018-2019)
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2014-2019)
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2014-2019)
Figure China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2018-2019)
Table China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2014-2019)
Table China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2014-2019)
Figure Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2018-2019)
Table Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2014-2019)
Table Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2018-2019)
Table Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2014-2019)
Figure India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2018-2019)
Table India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2014-2019)
Table India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2014-2019)
Figure Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2018-2019)
Table Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2014-2019)
Table Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2014-2019)
Table Astrazeneca Company Details
Table Astrazeneca Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019) (Million US$)
Figure Astrazeneca Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
Table Astrazeneca Recent Development
Table Roche Company Details
Table Roche Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
Table Roche Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
Table Pfizer Recent Development
Table AngioChem Company Details
Table AngioChem Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)(Million US$)
Figure AngioChem Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
Table AngioChem Recent Development
Table Vascular Biogeneics Company Details
Table Vascular Biogeneics Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)(Million US$)
Figure Vascular Biogeneics Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2014-2019)
Table Vascular Biogeneics Recent Development
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Share by Regions (2019-2025)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Share by Regions in 2025
Figure United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Product (2019-2025)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Product in 2025
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2019-2025)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 再発多形性膠芽腫（GBM）治療の世界市場：市場規模・現状・予測
    Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size, Status and Forecast 2019-2025
    QYR9ST05019 2019年9月2日 92Pages
    ※当調査レポートでは、再発多形性膠芽腫（GBM）治療の世界市場について調査・分析し、再発多形性膠芽腫（GBM）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口薬、テモゾロミド、放射線増感剤、...
  • 脱毛症（脱毛）治療の世界市場：市場規模・現状・予測
    Global Alopecia (Hair Loss)Treatment Market Size, Status and Forecast 2019-2025
    QYR9ST03573 2019年9月2日 90Pages
    ※当調査レポートでは、脱毛症（脱毛）治療の世界市場について調査・分析し、脱毛症（脱毛）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ビタミン及びサプリメント、シャンプー及びコンディショナー、そ...
  • 経口抗糖尿病（OAD）治療の世界市場：市場規模・現状・予測
    Global Oral Antidiabetic (OAD) Treatment Market Size, Status and Forecast 2019-2025
    QYR9ST04229 2019年9月2日 92Pages
    ※当調査レポートでは、経口抗糖尿病（OAD）治療の世界市場について調査・分析し、経口抗糖尿病（OAD）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（スルホニル尿素、ビグアナイド、腸管α-グルコ...
  • 筋萎縮性側索硬化症（ルーゲーリッグ病）治療の世界市場：市場規模・現状・予測
    Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size, Status and Forecast 2019-2025
    QYR9ST04097 2019年9月2日 95Pages
    ※当調査レポートでは、筋萎縮性側索硬化症（ルーゲーリッグ病）治療の世界市場について調査・分析し、筋萎縮性側索硬化症（ルーゲーリッグ病）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、幹...
  • 消化管間質腫瘍（GIST）治療の世界市場：市場規模・現状・予測
    Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size, Status and Forecast 2019-2025
    QYR9ST03640 2019年9月2日 94Pages
    ※当調査レポートでは、消化管間質腫瘍（GIST）治療の世界市場について調査・分析し、消化管間質腫瘍（GIST）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（手術、標的療法、放射線療法、化学療法...
  • 移植片対宿主病（GVHD）治療の世界市場：市場規模・現状・予測
    Global Graft Versus Host Disease (GVHD) Treatment Market Size, Status and Forecast 2019-2025
    QYR9ST03424 2019年9月2日 103Pages
    ※当調査レポートでは、移植片対宿主病（GVHD）治療の世界市場について調査・分析し、移植片対宿主病（GVHD）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（モノクローナル抗体、MTOR阻害剤、...
  • 若年性黄斑変性症（シュタルガルト病）治療の世界市場：市場規模・現状・予測
    Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size, Status and Forecast 2019-2025
    QYR9ST03668 2019年9月2日 93Pages
    ※当調査レポートでは、若年性黄斑変性症（シュタルガルト病）治療の世界市場について調査・分析し、若年性黄斑変性症（シュタルガルト病）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（幹細胞療法、遺伝...
  • 胆管がん（胆管細胞がん）治療の世界市場：市場規模・現状・予測
    Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size, Status and Forecast 2019-2025
    QYR9ST04116 2019年9月2日 90Pages
    ※当調査レポートでは、胆管がん（胆管細胞がん）治療の世界市場について調査・分析し、胆管がん（胆管細胞がん）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、放射線治療、手術）、用途別（肝...
  • 世界の膠芽腫治療薬市場：動向・競争分析
    Global Glioblastoma Treatment Drugs Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
    QYR9ST04313 2019年9月2日 119Pages
    ※本調査レポートでは、世界の膠芽腫治療薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。膠芽腫治療薬の種類別には、VEGF / VEGFR阻害剤、アルキル化剤、その他抗腫瘍薬に、用途別には、病院、癌研究機関、長期...
  • 世界の良性再発性肝内胆汁うっ滞（BRIC）画像診断装置市場：専門的調査
    Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Professional Survey Report 2019
    QYR9ST10454 2019年9月5日 112Pages
    ※本調査レポートは、良性再発性肝内胆汁うっ滞（BRIC）画像診断装置の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、X線、MRI、CT、核イメージングに、用途...
  • 再発多形性膠芽腫（GBM）治療の世界市場：市場規模・現状・予測再発多形性膠芽腫（GBM）治療の世界市場：市場規模・現状・予測 Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain.The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. In 2018, the global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was xx milli…
  • 世界の膠芽腫治療薬市場：動向・競争分析世界の膠芽腫治療薬市場：動向・競争分析 Glioblastoma also is known as glioblastoma multiforme, is a type of malignant brain tumor that develops from glial cells. It proliferates at a rapid rate and is difficult to cure however; the treatment drugs are often prescribed to ease the symptoms.In 2018, the global Glioblastoma Treatment Drugs m…
  • 経口抗糖尿病（OAD）治療の世界市場：市場規模・現状・予測経口抗糖尿病（OAD）治療の世界市場：市場規模・現状・予測 Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabet…
  • 肺癌治療薬の世界市場：市場規模・現状・予測肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
  • 肺癌治療薬の世界市場：市場規模・現状・予測肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …